Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
147
datasets available to search
ShareScore release 0.9.0
Dataset results
147 results for “vildagliptin”
Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)
ClinicalTrials.gov study NCT00765830. IPD Sharing: Not stated. Countries: 12. Publications: 0.
Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia
ClinicalTrials.gov study NCT04761861. IPD Sharing: YES. Countries: 1. Publications: 0.
Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00106340. IPD Sharing: Not stated. Countries: 2. Publications: 0.
The Vascular Effects of Vildagliptin in Insulin Resistant Individuals
ClinicalTrials.gov study NCT01122641. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
ClinicalTrials.gov study NCT01426802. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression
ClinicalTrials.gov study NCT04485845. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Gosogliptin as Monotherapy and in Combination With Metformin vs. Vildagliptin as Monotherapy and in Combination With Metformin in Drug-naive Type 2 Diabetic Patients.
ClinicalTrials.gov study NCT03088670. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00099957. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vildagliptin 100 mg Once Daily vs. Placebo as add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
ClinicalTrials.gov study NCT00494884. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Galvus (Vildagliptin) vs Placebo in Combination With Metformin and Insulin
ClinicalTrials.gov study NCT01757587. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long-Term Safety Study of Vildagliptin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00325429. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00821977. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Comparison of Once-Weekly Trelagliptin Vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 Diabetes
ClinicalTrials.gov study NCT06889909. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome
ClinicalTrials.gov study NCT06142656. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00382096. IPD Sharing: Not stated. Countries: 2. Publications: 0.
The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients
ClinicalTrials.gov study NCT04410341. IPD Sharing: YES. Countries: 1. Publications: 0.
Functional Improvement of Progenitor Cells and Endothelial Function by Vildagliptin in Diabetes Mellitus (FINNjA-DM).
ClinicalTrials.gov study NCT00936234. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 3 Study to Compare the Efficacy and Safety of Gemigliptin and Vildagliptin as Add-on Therapy to Metformin in People With Type 2 Diabetes Inadequately Controlled With Metformin
ClinicalTrials.gov study NCT02343926. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00860288. IPD Sharing: Not stated. Countries: 21. Publications: 0.
Comparison of Once-Weekly Trelagliptin vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 Diabetes
ClinicalTrials.gov study NCT06913101. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.